BioNexus Gene Lab Corp. Finance Lease, Liability
BioNexus Gene Lab Corp. (BGLC) had Finance Lease, Liability of $52.56 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:FinanceLeaseLiability · last filed 2026-08-14
- 2026-06-30: Finance Lease, Liability $52.56K.
- 2026-03-31: Finance Lease, Liability $54.38K.
- 2025-12-31: Finance Lease, Liability $0.00.
- 2022-03-31: Finance Lease, Liability $34.05K.
| Period end | Finance Lease, Liability |
|---|---|
| 2026-06-30 | $52.56K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $54.38K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 |
| 2022-03-31 | $34.05K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $34.04K 10-Q · filed 2022-05-16 |
| 2021-09-30 | $39.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $44.99K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $51.79K 10-Q · filed 2021-05-18 |
| 2020-12-31 | $60.34K 10-K · filed 2022-04-06 |
| 2020-09-30 | $59.39K 10-Q/A · filed 2020-11-09 |
| 2020-06-30 | $57.68K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $57.39K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $65.29K 10-K · filed 2021-03-30 |
| 2019-09-30 | $68.61K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $74.14K 10-Q · filed 2019-08-09 |
| 2018-12-31 | $82.06K 10-K · filed 2020-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |